Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

IMGN

Immunogen, Inc.

Nov 30 • 01:12PM ET

29.30

Dollar change +13.24
Percentage change 82.44	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.30	Insider Own	2.57%	Shs Outstand	266.26M	Perf Week	81.54%
Market Cap	7.80B	Forward P/E	81.31	EPS next Y	0.36	Insider Trans	-38.25%	Shs Float	259.43M	Perf Month	97.17%
Income	-73.52M	PEG	-	EPS next Q	0.12	Inst Own	91.24%	Short Float / Ratio	12.59% / 6.74	Perf Quarter	84.97%
Sales	287.61M	P/S	27.12	EPS this Y	107.44%	Inst Trans	1.68%	Short Interest	32.66M	Perf Half Y	106.77%
Book/sh	2.11	P/B	13.87	EPS next Y	450.37%	ROA	-12.45%	Target Price	23.29	Perf Year	484.83%
Cash/sh	2.27	P/C	12.88	EPS next 5Y	-	ROE	-19.88%	52W Range	3.61 - 20.69	Perf YTD	490.73%
Dividend	-	P/FCF	-	EPS past 5Y	2.15%	ROI	-11.17%	52W High	41.61%	Beta	0.82
Dividend %	-	Quick Ratio	5.65	Sales past 5Y	13.91%	Gross Margin	98.51%	52W Low	712.76%	ATR	1.72
Employees	277	Current Ratio	5.70	Sales Q/Q	637.72%	Oper. Margin	-27.88%	RSI (14)	87.59	Volatility	4.53% 5.63%
Optionable	Yes	Debt/Eq	0.20	EPS Q/Q	134.85%	Profit Margin	-25.56%	Rel Volume	17.39	Prev Close	16.06
Shortable	Yes	LT Debt/Eq	0.17	Earnings	Nov 02 BMO	Payout	-	Avg Volume	4.84M	Price	29.30
Recom	1.56	SMA20	87.60%	SMA50	93.98%	SMA200	130.24%	Volume	49,767,585	Change	82.44%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-20-23	Initiated	Goldman	Neutral	$17
Nov-09-23	Initiated	Deutsche Bank	Buy	$25
Oct-06-23	Initiated	Oppenheimer	Perform	$16
May-03-23	Upgrade	Piper Sandler	Neutral → Overweight	$6 → $16
Nov-21-22	Initiated	Truist	Buy	$10
Sep-09-22	Initiated	Barclays	Overweight	$8
Mar-21-22	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$9 → $6
Feb-11-22	Initiated	BMO Capital Markets	Outperform	$18
Dec-01-21	Upgrade	Jefferies	Hold → Buy	$7 → $12
Oct-26-20	Resumed	H.C. Wainwright	Buy	$11
Oct-02-20	Upgrade	Guggenheim	Neutral → Buy	$14
Sep-29-20	Resumed	JP Morgan	Neutral
Dec-17-19	Reiterated	H.C. Wainwright	Buy	$5 → $9
Aug-13-19	Reiterated	H.C. Wainwright	Buy	$4 → $5
May-15-19	Downgrade	Guggenheim	Buy → Neutral
May-06-19	Upgrade	H.C. Wainwright	Neutral → Buy	$7
May-06-19	Upgrade	Cowen	Market Perform → Outperform
Mar-19-19	Downgrade	JP Morgan	Neutral → Underweight
Mar-05-19	Upgrade	Morgan Stanley	Underweight → Equal-Weight
Mar-04-19	Downgrade	SVB Leerink	Outperform → Mkt Perform

Show Previous Ratings

Today 11:49AM	AbbVie Pays $10.1 Billion for ImmunoGen to Expand Its Cancer Drug Portfolio (Investopedia) +82.44%
10:40AM	ImmunoGen Stock Soars 81% on AbbVies $10.1 Billion Takeover (Barrons.com)
10:38AM	Why Is ImmunoGen (IMGN) Stock Up 81% Today? (InvestorPlace)
10:37AM	AbbVie to Buy Cancer Biotech ImmunoGen for More Than $10 Billion (The Wall Street Journal)
10:32AM	AbbVie To Buy ImmunoGen, Cancer Drug Maker, In $10.1 Billion Cash Deal (Investor's Business Daily)
10:12AM	Loading…
10:12AM	SHAREHOLDER NEWS: Johnson Fistel Investigates Proposed Sale of ImmunoGen (GlobeNewswire)
09:44AM	Biotech Stocks Rally After $10.1 Billion ImmunoGen Buyout (The Wall Street Journal)
09:30AM	ImmunoGen (IMGN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
08:19AM	Drugmaker AbbVie to spend over $10B on ImmunoGen to juice its cancer-fighting treatment portfolio (Associated Press Finance)
08:18AM	AbbVie to Acquire ImmunoGen in $10 Billion Deal (Barrons.com)
07:51AM	AbbVie to Buy ImmunoGen for More Than $10 Billion (The Wall Street Journal)
07:45AM	AbbVie seeks lift from 'guided missile' cancer drug with $10 billion ImmunoGen deal (Reuters)
07:41AM	UPDATE 3-AbbVie signs $10 bln deal to buy cancer drugmaker ImmunoGen (Reuters)
07:33AM	AbbVie to buy ImmunoGen for $10.1 billion (Reuters)
07:30AM	AbbVie to Acquire ImmunoGen, including its Flagship Cancer Therapy ELAHERE (mirvetuximab soravtansine-gynx), Expanding Solid Tumor Portfolio (PR Newswire)
01:47PM	Loading…
Nov-27-23 01:47PM	Biotech Leader ImmunoGen Eyes Early Buy Point Amid Path To Profitability (Investor's Business Daily)
Nov-22-23 09:55AM	Wall Street Analysts Believe ImmunoGen (IMGN) Could Rally 52.99%: Here's is How to Trade (Zacks) +6.11%
08:57AM	Are Options Traders Betting on a Big Move in ImmunoGen (IMGN) Stock? (Zacks)
Nov-18-23 09:03AM	Insider Sell: SVP & Chief Business Officer Stacy Coen Sells 108,609 Shares of Immunogen Inc ... (GuruFocus.com)
Nov-15-23 09:35AM	ImmunoGen (IMGN) Just Overtook the 20-Day Moving Average (Zacks)
09:30AM	ImmunoGen (IMGN) Crossed Above the 50-Day Moving Average: What That Means for Investors (Zacks)
Nov-06-23 09:55AM	Wall Street Analysts See a 40.58% Upside in ImmunoGen (IMGN): Can the Stock Really Move This High? (Zacks)
Nov-04-23 12:16PM	12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds (Insider Monkey)
Nov-03-23 04:22PM	ImmunoGen, Inc. (NASDAQ:IMGN) Q3 2023 Earnings Call Transcript (Insider Monkey) +5.10%
12:18PM	ImmunoGen (IMGN) Q3 Earnings Beat, Elahere Drives Revenues (Zacks)
Nov-02-23 04:30PM	ImmunoGen Announces Webcast of Presentation and Q&A at Upcoming Jefferies London Healthcare Conference (Business Wire)
07:54AM	Immunogen Inc (IMGN) Reports Q3 2023 Earnings: Net Income of $30.7 Million (GuruFocus.com)
07:50AM	ImmunoGen (IMGN) Q3 Earnings and Revenues Top Estimates (Zacks)
06:47AM	ImmunoGen: Q3 Earnings Snapshot (Associated Press Finance)
06:30AM	ImmunoGen Reports Recent Progress and Third Quarter 2023 Financial Results (Business Wire)
04:30PM	Loading…
Nov-01-23 04:30PM	ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Oct-31-23 10:01AM	Earnings Preview: Catalent (CTLT) Q1 Earnings Expected to Decline (Zacks) +5.84%
Oct-30-23 02:07PM	10 Low Risk High Reward Stocks Set to Triple By 2027 (Insider Monkey) -6.40%
Oct-27-23 06:30AM	ImmunoGen Announces European Medicines Agency Acceptance of Marketing Authorization Application for Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer (Business Wire)
Oct-26-23 10:02AM	ImmunoGen (IMGN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks) +8.04%
Oct-25-23 08:34AM	Strength Seen in ImmunoGen (IMGN): Can Its 11.7% Jump Turn into More Strength? (Zacks)
Oct-24-23 01:22AM	Zacks Investment Ideas feature highlights: Fresenius Medical Care, Vericel and ImmunoGen (Zacks) +11.72%
Oct-23-23 05:59PM	Top Medical Stocks to Buy Amid Recent Market Volatility (Zacks) -11.94%
08:30AM	Anixa Biosciences Appoints Accomplished Medical Oncologist and Biotechnology Executive, Dr. Mark A. Goldberg, to Cancer Business Advisory Board (PR Newswire)
Oct-20-23 01:22PM	12 Best Performing Biotech Stocks in 2023 (Insider Monkey)
09:00AM	How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings (Zacks)
Oct-19-23 04:01PM	ImmunoGen Announces Conference Call to Discuss Its Third Quarter 2023 Operating Results (Business Wire)
Oct-06-23 09:42AM	e.l.f. Beauty upgraded, AutoZone downgraded: Wall Street's top analyst calls (The Fly)
Oct-04-23 09:55AM	Wall Street Analysts Think ImmunoGen (IMGN) Could Surge 49.11%: Read This Before Placing a Bet (Zacks)
Sep-29-23 05:00PM	ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Sep-28-23 07:00AM	ELAHERE Shows Overall and Progression-Free Survival Benefit Regardless of Prior PARPi Exposure or Prior Lines of Therapy in FR-Positive Platinum-Resistant Ovarian Cancer (Business Wire)
Sep-18-23 05:09PM	These 7 Stocks Are Outperforming Nvidia In 2023 (Investor's Business Daily)
05:00PM	ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
06:30AM	ImmunoGen Appoints Lauren White as Senior Vice President and Chief Financial Officer (Business Wire)
Sep-14-23 02:02PM	10 Stocks Receiving a Massive Vote of Approval From Wall Street Analysts (Insider Monkey)
Sep-07-23 07:08AM	7 Pharma Stocks to Buy for Groundbreaking Treatments and Robust Revenue Growth (InvestorPlace)
Sep-05-23 04:30PM	ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Aug-28-23 06:30AM	ImmunoGen Announces Collaboration with Takeda to Develop and Commercialize ELAHERE® in Japan (Business Wire)
Aug-21-23 04:20PM	These Are the ONLY 3 Biotech Stocks to Consider in August 2023 (InvestorPlace)
Aug-17-23 06:40AM	7 A-Rated Biotech Stocks for Your August Buy List (InvestorPlace)
Aug-01-23 04:30PM	ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
10:09AM	ImmunoGen (IMGN) Stock Down Despite Q2 Earnings & Sales Beat (Zacks)
10:00AM	Best Momentum Stocks to Buy for August 1st (Zacks)
09:25AM	Rainbows and Unicorns: ImmunoGen, Inc. (NASDAQ:IMGN) Analysts Just Became A Lot More Optimistic (Simply Wall St.)
02:16AM	Q2 2023 ImmunoGen Inc Earnings Call (Thomson Reuters StreetEvents)
Jul-31-23 07:55AM	ImmunoGen (IMGN) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -8.71%
06:43AM	ImmunoGen: Q2 Earnings Snapshot (AP Finance)
06:35AM	ImmunoGen Announces Departure of Anna Berkenblit, Chief Medical Officer (Business Wire)
06:30AM	ImmunoGen Reports Recent Progress and Second Quarter 2023 Financial Results (Business Wire)
Jul-27-23 04:30PM	ImmunoGen Announces Webcast of Presentation and Q&A at Upcoming Canaccord Genuity 43rd Annual Growth Conference (Business Wire)
Jul-26-23 06:58AM	Institutional investors in ImmunoGen, Inc. (NASDAQ:IMGN) lost 9.0% last week but have reaped the benefits of longer-term growth (Simply Wall St.)
Jul-25-23 10:01AM	Neurocrine Biosciences (NBIX) Earnings Expected to Grow: Should You Buy? (Zacks)
Jul-24-23 10:00AM	ImmunoGen (IMGN) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release (Zacks)
06:30AM	ImmunoGen Announces Multi-Target License and Option Agreement with ImmunoBiochem to Develop Next-Generation Antibody-Drug Conjugates (Business Wire)
Jul-18-23 09:40AM	Are Medical Stocks Lagging ANI Pharmaceuticals (ANIP) This Year? (Zacks)
Jul-17-23 04:01PM	ImmunoGen Announces Conference Call to Discuss Its Second Quarter 2023 Operating Results (Business Wire)
09:35AM	ImmunoGen (IMGN) Crossed Above the 20-Day Moving Average: What That Means for Investors (Zacks)
Jul-13-23 10:48AM	Aridis (ARDS) Up on Receiving FDA's QIDP Designation for AR-301 (Zacks)
Jul-06-23 04:43PM	3 Biotech Stocks to Make Your Get Rich Dreams Come True (InvestorPlace)
Jul-03-23 04:30PM	ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Jul-02-23 02:11PM	5 Sizzling Stocks That Are Outperformers in the Market This Year (InvestorPlace)
Jun-27-23 09:50AM	Avalo (AVTX) Fails to Meet Goal in Asthma Study, Stock Down 89% (Zacks)
Jun-09-23 01:32PM	Midcap Biotech Stock ImmunoGen is Shooting Higher Today: Here's Why (Benzinga) +8.95%
05:33AM	ImmunoGen shares jump after Barclays raises price target of biotech firm (Investing.com)
03:00AM	ImmunoGen Presents Updated Findings from CADENZA Trial of Pivekimab Sunirine in Blastic Plasmacytoid Dendritic Cell Neoplasm at EHA 2023 Congress (Business Wire)
Jun-08-23 11:31AM	Why Is Nektar (NKTR) Down 19.7% Since Last Earnings Report? (Zacks) +7.07%
Jun-07-23 11:30AM	Why Is Theravance Bio (TBPH) Down 3.8% Since Last Earnings Report? (Zacks)
Jun-06-23 06:50AM	Dr. Reddy's (RDY) Meets Goals in Actemra Biosimilar Study (Zacks)
06:31AM	An Intrinsic Calculation For ImmunoGen, Inc. (NASDAQ:IMGN) Suggests It's 47% Undervalued (Simply Wall St.)
Jun-05-23 04:06PM	ImmunoGen, Day One Surge On Cancer Drug Updates, But Arcus Dips (Investor's Business Daily) +6.96%
Jun-04-23 08:00AM	ELAHERE® Demonstrates 35% Reduction in the Risk of Disease Progression or Death Versus Chemotherapy in FR-Positive Platinum-Resistant Ovarian Cancer (Business Wire)
Jun-02-23 11:31AM	Ionis Pharmaceuticals (IONS) Up 19.3% Since Last Earnings Report: Can It Continue? (Zacks)
Jun-01-23 04:30PM	ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
May-24-23 04:30PM	ImmunoGen Announces Webcast of Presentation and Q&A at Upcoming Jefferies Healthcare Conference (Business Wire)
May-22-23 06:59AM	When Will ImmunoGen, Inc. (NASDAQ:IMGN) Breakeven? (Simply Wall St.)
May-19-23 11:09AM	Here's Why You Should Add ImmunoGen (IMGN) to Your Portfolio Now (Zacks)
10:00AM	3 Biotech Stocks That Are Revolutionizing Healthcare in 2023 (InvestorPlace)
May-12-23 12:08PM	ImmunoGen (IMGN) Stock Surges 230% in a Month: Here's Why (Zacks)
May-11-23 09:58AM	Dr. Reddy's (RDY) Q4 Earnings and Revenues Beat Estimates (Zacks)
09:55AM	Should You Buy ImmunoGen (IMGN) After Golden Cross? (Zacks)
May-09-23 04:01PM	ImmunoGen Announces Closing of Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares (Business Wire)
06:30AM	ImmunoGen Announces Results from the Phase 3 MIRASOL Trial Selected as Late-Breaking Presentation for ASCO 2023 Annual Meeting (Business Wire)
May-04-23 07:45PM	ImmunoGen Announces Pricing of Upsized Public Offering of Common Stock (Business Wire) +8.32%
02:30PM	Immunogen Stock Shows Market Leadership With Jump To 99 RS Rating (Investor's Business Daily)
May-03-23 05:39PM	Biotech ImmunoGen Stock Jumps 140% After Positive Drug Trial Data (Barrons.com) +135.77%

ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Coen Stacy Ann	SVP & CHIEF BUSINESS OFFICER	Nov 17	Option Exercise	7.61	78,223	595,441	115,189	Nov 17 07:52 PM
Coen Stacy Ann	SVP & CHIEF BUSINESS OFFICER	Nov 17	Sale	16.05	78,223	1,255,479	36,966	Nov 17 07:52 PM
Coen Stacy Ann	SVP & CHIEF BUSINESS OFFICER	Nov 16	Option Exercise	5.53	4,100	22,665	41,066	Nov 17 07:52 PM
Coen Stacy Ann	SVP & CHIEF BUSINESS OFFICER	Nov 16	Sale	16.01	4,100	65,641	36,966	Nov 17 07:52 PM
Wingrove Theresa	SVP OF REGULATORY AFFAIRS	Nov 15	Option Exercise	4.55	166,725	758,599	169,536	Nov 17 07:53 PM
Coen Stacy Ann	SVP & CHIEF BUSINESS OFFICER	Nov 15	Option Exercise	5.48	26,286	144,008	63,252	Nov 17 07:52 PM
Wingrove Theresa	SVP OF REGULATORY AFFAIRS	Nov 15	Sale	15.85	166,725	2,642,591	2,811	Nov 17 07:53 PM
Coen Stacy Ann	SVP & CHIEF BUSINESS OFFICER	Nov 15	Sale	16.01	26,286	420,839	36,966	Nov 17 07:52 PM
Wingrove Theresa	SVP OF REGULATORY AFFAIRS	Nov 07	Option Exercise	10.65	19,517	207,856	22,328	Nov 08 05:56 PM
Wallace Richard John	Director	Nov 07	Option Exercise	14.70	10,000	147,000	10,000	Nov 08 05:53 PM
Wingrove Theresa	SVP OF REGULATORY AFFAIRS	Nov 07	Sale	16.66	19,517	325,153	2,811	Nov 08 05:56 PM
Lentini Renee	VP & PRIN ACCTG OFFICER	Nov 06	Option Exercise	7.83	120,528	943,442	219,545	Nov 08 05:55 PM
Lentini Renee	VP & PRIN ACCTG OFFICER	Nov 06	Sale	15.29	219,545	3,356,843	0	Nov 08 05:55 PM
Goldberg Mark Alan	Director	Oct 30	Option Exercise	14.70	10,000	147,000	70,151	Nov 01 05:59 PM
Wingrove Theresa	SVP OF REGULATORY AFFAIRS	Oct 16	Option Exercise	4.55	192,004	873,618	194,815	Oct 18 04:25 PM
Wingrove Theresa	SVP OF REGULATORY AFFAIRS	Oct 16	Sale	14.40	192,004	2,764,858	2,811	Oct 18 04:25 PM
MITCHELL DEAN J	Director	Sep 22	Option Exercise	14.70	10,000	147,000	152,667	Sep 26 04:08 PM
Wingrove Theresa	SVP OF REGULATORY AFFAIRS	Sep 15	Option Exercise	3.65	108,668	397,064	194,824	Sep 19 05:27 PM
Wingrove Theresa	SVP OF REGULATORY AFFAIRS	Sep 15	Sale	15.44	192,013	2,964,681	2,811	Sep 19 05:27 PM
Peterson Kristine	Director	Sep 13	Option Exercise	14.70	10,000	147,000	10,000	Sep 14 05:31 PM
MCCLUSKI STEPHEN C	Director	Sep 13	Option Exercise	14.70	10,000	147,000	10,000	Sep 14 05:30 PM
Lentini Renee	PRIN. FIN & ACCTG. OFF.	Sep 12	Option Exercise	3.97	25,141	99,808	99,017	Sep 14 05:29 PM
Coen Stacy Ann	SVP & CHIEF BUSINESS OFFICER	Sep 08	Option Exercise	7.69	26,006	199,986	36,966	Sep 11 04:08 PM
Coen Stacy Ann	SVP & CHIEF BUSINESS OFFICER	Aug 09	Option Exercise	4.92	100,210	493,033	111,170	Aug 11 05:02 PM
Coen Stacy Ann	SVP & CHIEF BUSINESS OFFICER	Aug 09	Sale	14.20	100,210	1,422,982	10,960	Aug 11 05:02 PM
Enyedy Mark J	CHIEF EXECUTIVE OFFICER	Aug 04	Option Exercise	5.34	1,104,218	5,901,760	1,545,667	Aug 04 07:32 PM
Coen Stacy Ann	SVP & CHIEF BUSINESS OFFICER	Aug 04	Option Exercise	4.92	80,326	395,204	91,286	Aug 04 07:33 PM
Enyedy Mark J	CHIEF EXECUTIVE OFFICER	Aug 04	Sale	16.96	992,397	16,831,053	553,270	Aug 04 07:32 PM
Coen Stacy Ann	SVP & CHIEF BUSINESS OFFICER	Aug 04	Sale	17.05	80,326	1,369,558	10,960	Aug 04 07:33 PM
Enyedy Mark J	CHIEF EXECUTIVE OFFICER	Aug 03	Option Exercise	4.55	1,020,000	4,642,932	1,461,449	Aug 04 07:32 PM
Lentini Renee	PRIN. FIN & ACCTG. OFF.	Aug 03	Option Exercise	2.45	51,033	124,907	73,876	Aug 04 07:28 PM
Enyedy Mark J	CHIEF EXECUTIVE OFFICER	Aug 03	Sale	16.61	1,020,000	16,942,200	441,449	Aug 04 07:32 PM
Enyedy Mark J	CHIEF EXECUTIVE OFFICER	Aug 02	Option Exercise	4.55	995,157	4,527,964	1,436,606	Aug 04 07:32 PM
Lentini Renee	PRIN. FIN & ACCTG. OFF.	Aug 02	Option Exercise	4.57	148,277	677,777	171,120	Aug 04 07:28 PM
Coen Stacy Ann	SVP & CHIEF BUSINESS OFFICER	Aug 02	Option Exercise	4.92	4,255	20,935	15,215	Aug 04 07:33 PM
Enyedy Mark J	CHIEF EXECUTIVE OFFICER	Aug 02	Sale	17.46	995,157	17,371,535	441,449	Aug 04 07:32 PM
Lentini Renee	PRIN. FIN & ACCTG. OFF.	Aug 02	Sale	17.55	148,277	2,602,261	22,843	Aug 04 07:28 PM
Coen Stacy Ann	SVP & CHIEF BUSINESS OFFICER	Aug 02	Sale	18.12	4,255	77,101	10,960	Aug 04 07:33 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

IMGN

Immunogen, Inc.

Upgrade your FINVIZ experience